Industry News

Industry News

Improving The Development Of New Cancer Models Using An Advanced Biomedical Imaging Method

Dec 23, 2012

Scientists at the University of Arizona Cancer Center and the Moffitt Cancer Center, led by Dr. Robert Gillies, have demonstrated that an advanced magnetic resonance imaging (MRI) method can non-invasively evaluate the cellular proliferation of tumor models of breast cancer... Read More

Mayo Clinic-Led Study Unravels Biological Pathway That Controls The Leakiness Of Blood Vessels

Dec 22, 2012

A research team led by scientists at Mayo Clinic in Florida have decoded the entire pathway that regulates leakiness of blood vessels - a condition that promotes a wide number of disorders, such as heart disease, cancer growth and spread, inflammation and respiratory distress. They say their findings, published online Dec... Read More

Cancer Diagnosis Later In Life Poses Significant Risk To Offspring

Dec 21, 2012

But highest familial risk still in relatives whose parents diagnosed at earlier ages Relatives of family members diagnosed with cancer are still at risk of the disease even if the diagnosis came at an older age, suggests a paper published on bmj.com today... Read More

A Trio Of MicroRNAs Contributes To Liver Cancer Progression

Dec 21, 2012

MicroRNAs are small RNA molecules that regulate the expression of various genes. In this issue of the Journal of Clinical Investigation, researchers led by Shelly Lu at the University of Southern California identified a trio of microRNAs that reduce the expression of MAT1A. Reduced MAT1A expression is correlated with a worse prognosis in hepatocellular carcinoma (HCC; liver cancer)... Read More

Researchers Identify A New Player In Tumor Angiogenesis

Dec 21, 2012

Angiogenesis, or the formation of new blood vessels, is important for tumor growth; however, while many regulatory growth factors have been identified, little is known about the genetic regulation that promotes tumor angiogenesis... Read More

Breast Cancer Cells Growing In 3D-Matrix Revert To Normal

Dec 21, 2012

Human breast cancer cells growing in the lab on a three-dimensional (3-D) extracellular matrix reverted to a normal phenotype when subjected to compression force applied by an elastic chamber, researchers reported on Dec. 17 at the American Society for Cell Biology Annual Meeting in San Francisco... Read More

MicroRNA Drives Breast Cancer Metastasis By Promoting Cancer Cell Survival

Dec 21, 2012

Tumor metastasis, which accounts for the majority of deaths in breast cancer patients, is a process by which cancer cells acquire the ability to invade tissue and survive in other parts of the body. Dysregulation of the protein TGF-β is known to drive breast cancer metastasis, but the precise molecular mechanisms are unknown... Read More

Breast Cancer Cells Interact With Non-Cancerous Tissue To Drive Metastasis

Dec 21, 2012

In addition to mutations, environmental conditions created by the tissues surrounding tumors (stroma) play a major role in cancer progression. In this issue of the Journal of Clinical Investigation, researchers led by Gregg Semenza at Johns Hopkins University examined the interactions between breast cancer cells and the stroma to identify underlying pro-metastatic molecular mechanisms... Read More

Researchers Identify Rituximab-Insensitive Cells In Patients With Refractory Thrombocytopenia Purpura

Dec 21, 2012

Primary immune thrombocytopenia purpura (ITP) is a bleeding disorder in which the immune system generates antibodies that destroy platelets, the cells that cause blood to clot. B cells, immune cells that produce the antibodies that recognize the platelets, develop in the spleen... Read More

PRT Versus IMRT Toxicity In Medicare Beneficiaries With Prostate Cancer

Dec 21, 2012

There is no difference between proton radiotherapy (PRT) and intensity-modulated radiotherapy (IMRT) when comparing the toxicity among Medicare beneficiary patients with prostate cancer at 12 months post-treatment according to a study published December 14 in the Journal of the National Cancer Institute... Read More

Previous Page   Next Page